Disease · MONDO_0005260
Comparisons in its trials28
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 20 of 28
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Memantine to Memantine vs Placebo to Memantine: serious adverse events | 0 of 52 | 1 of 50 | 102 | NCT01999894 | Trial comparisons |
| Aripiprazole vs Placebo: serious adverse events | 0 of 47 | 0 of 50 | 97 | NCT00332241 | Trial comparisons |
| Aripiprazole vs Placebo: serious adverse events | 0 of 47 | 1 of 45 | 92 | NCT01617447 | Trial comparisons |
| Active vs Placebo: serious adverse events | 0 of 27 | 0 of 24 | 51 | NCT01039792 | Trial comparisons |
| Sapropterin vs Placebo: Clinical Global Impression -- Severity (CGI-S) Scale | 3 of 23 | 1 of 23 | 46 | NCT00850070 | Trial comparisons |
| Sapropterin vs Placebo: Clinical Global Impression -- Improvement (CGI-I) Scale | 5 of 23 | 3 of 23 | 46 | NCT00850070 | Trial comparisons |
| Sapropterin vs Placebo: serious adverse events | 2 of 23 | 1 of 23 | 46 | NCT00850070 | Trial comparisons |
| Kuvan Following Active Treatment vs Kuvan Following Placebo: serious adverse events | 0 of 20 | 0 of 21 | 41 | NCT00943579 | Trial comparisons |
| Sulforaphane-rich Broccoli Sprout Extract vs Placebo: serious adverse events | 0 of 26 | 0 of 14 | 40 | NCT01474993 | Trial comparisons |
| Memantine vs Placebo: Treatment Responder | 9 of 19 | 4 of 21 | 40 | NCT01972074 | Trial comparisons |
| Oxytocin Nasal Spray vs Placebo Nasal Spray: deaths from any cause | 0 of 14 | 0 of 18 | 32 | NCT01624194 | Trial comparisons |
| Oxytocin Nasal Spray vs Placebo Nasal Spray: serious adverse events | 0 of 14 | 0 of 18 | 32 | NCT01624194 | Trial comparisons |
| Mirtazapine vs Placebo: deaths from any cause | 0 of 20 | 0 of 10 | 30 | NCT01302964 | Trial comparisons |
| Mirtazapine vs Placebo: serious adverse events | 0 of 20 | 0 of 10 | 30 | NCT01302964 | Trial comparisons |
| N-Acetyl Cysteine vs Sugar Pill: serious adverse events | 0 of 14 | 0 of 15 | 29 | NCT00627705 | Trial comparisons |
| Divalproex Sodium vs Placebo: Number of Participants Reporting Improvement on the Clinical Global Impression | 10 of 16 | 1 of 11 | 27 | NCT00211757 | Trial comparisons |
| Divalproex Sodium vs Placebo: deaths from any cause | 0 of 16 | 0 of 11 | 27 | NCT00211757 | Trial comparisons |
| Divalproex Sodium vs Placebo: serious adverse events | 0 of 16 | 0 of 11 | 27 | NCT00211757 | Trial comparisons |
| Sequence 2: Placebo:Oxytocin vs Sequence 1: Oxytocin:Oxytocin: Number of Participants Who Could Tolerate Twice Daily Oxytocin | 13 of 13 | 11 of 12 | 25 | NCT01308749 | Trial comparisons |
| Sequence 2: Placebo:Oxytocin vs Sequence 2: Oxytocin:Oxytocin: Number of Participants Who Could Tolerate Twice Daily Oxytocin | 11 of 13 | 11 of 12 | 25 | NCT01308749 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0005260/comparisons